Suppr超能文献

接受透析治疗的婴幼儿死亡风险因素。

Risk factors for mortality in infants and young children on dialysis.

作者信息

Wood E G, Hand M, Briscoe D M, Donaldson L A, Yiu V, Harley F L, Warady B A, Ellis E N

机构信息

Department of Pediatrics, Division of Pediatric Nephrology, Saint Louis University School of Medicine, Cardinal Glennon Children's Hospital, St Louis, MO, USA.

出版信息

Am J Kidney Dis. 2001 Mar;37(3):573-9.

Abstract

The factors associated with a greater mortality risk in infants and young children undergoing dialysis have not been clearly determined. We report the results of a North American Pediatric Renal Transplant Cooperative Study designed to assess risk factors in patients aged younger than 6 years at initiation of dialysis therapy. Sixty-four nonsurvivors were matched with 110 survivors for age at dialysis initiation, primary renal disease, and year of entry onto the database. Questionnaires on 137 patients (51 nonsurvivors, 86 survivors) were completed by participating centers. Seventy-five percent (103 of 137 patients) of the patients were aged younger than 2 years at dialysis initiation; 42% (58 of 137 patients) had renal aplasia, dysplasia, and/or hypoplasia or obstructive uropathy; 62% were boys; and 62% were white. One-year patient survival rates were 83% in infants beginning dialysis at younger than 3 months of age, 89% in 3- to 23-month-olds, and 95% in 2- to 5-year-olds (P = 0.001). Comorbid nonrenal disease occurred in 37 of 51 nonsurvivors (74%) versus 46 of 84 survivors (55%; P = 0.027). Nonsurvivors had pulmonary disease and/or hypoplasia more often (14 of 37 nonsurvivors; 37.8% versus 8 of 46 survivors; 17.4%; P = 0.04). Oliguria or anuria was present in 23 of 33 nonsurvivors (70%) aged younger than 2 years versus 26 of 64 survivors (41%; P = 0.007). Infection accounted for 15 of 51 deaths (29.4%). In summary, these results suggest that age at dialysis initiation; presence of nonrenal disease, particularly pulmonary disease and/or hypoplasia; and oliguria or anuria in children aged younger than 2 years are identifiable as risk factors for mortality in these young patients.

摘要

接受透析治疗的婴幼儿死亡风险较高的相关因素尚未明确确定。我们报告了一项北美儿科肾移植协作研究的结果,该研究旨在评估开始透析治疗时年龄小于6岁患者的风险因素。64名非幸存者与110名幸存者在开始透析时的年龄、原发性肾病以及进入数据库的年份方面进行了匹配。参与中心完成了对137名患者(51名非幸存者,86名幸存者)的问卷调查。75%(137名患者中的103名)患者在开始透析时年龄小于2岁;42%(137名患者中的58名)患有肾发育不全、发育异常和/或发育不良或梗阻性尿路病;62%为男孩;62%为白人。3个月龄以下开始透析的婴儿1年患者生存率为83%,3至23个月龄的婴儿为89%,2至5岁的儿童为95%(P = 0.001)。51名非幸存者中有37名(74%)发生了合并性非肾脏疾病,而84名幸存者中有46名(55%)发生了合并性非肾脏疾病(P = 0.027)。非幸存者肺部疾病和/或发育不全更为常见(37名非幸存者中的14名;37.8%对46名幸存者中的8名;17.4%;P = 0.04)。2岁以下的33名非幸存者中有23名(70%)出现少尿或无尿,而64名幸存者中有26名(41%)出现少尿或无尿(P = 0.007)。感染占51例死亡中的15例(29.4%)。总之,这些结果表明,开始透析时的年龄;合并性非肾脏疾病的存在,尤其是肺部疾病和/或发育不全;以及2岁以下儿童的少尿或无尿可被确定为这些年轻患者死亡的风险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验